Hemispherian: Funding, Investors & Team (Sep 2026)
Hemispherian is a company in the field of biotechnology, specializing in developing innovative therapies for various forms of cancer.
Hemispherian has raised $10.2M across 3 funding rounds on record, the most recent an undisclosed round of $1.5M announced in Dec 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Hemispherian Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Hemispherian Funding Rounds
Hemispherian raised $1.3M in a Seed announced in May 2022.
5 months later, an undisclosed round of $7.4M was announced in Oct 2022.
1.2 years later, an undisclosed round of $1.5M was announced in Dec 2023.
Hemispherian Founders and Leadership Team
Contact details for the Hemispherian team: 1 of 1 has an email address on file.
Start 14-day free trial →Hemispherian Funding Compared to Other Biotechnology Startups
Hemispherian's latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hemispherian in Biotechnology and Oslo
Companies Similar to Hemispherian
Zelluna Immunotherapy AS is a privately owned Norwegian biopharmaceutical company founded in 2016 focused on…
Hofseth BioCare's key goal is to offer high benefit added biomarine elements for human applications. Through…
Circio Holding ASA is a company in the clinical stage that is developing immune activators for challenging…
IDEX, a biometrics software and fingerprint authentication company based in Oslo, Norway, was established in…
Arctic Bioscience is a biotechnology research company that develops products, solutions, and technologies…
Lytix Biopharma AS is a privately-owned pharmaceutical company focussed on anti-microbials and cancer…
Actithera is a company specializing in developing radioligand therapies through the application of medicinal…
NoMy is a company focused on creating sustainable and scalable solutions for alternative proteins by…
Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of…
Biosergen AS develops variants of nystatin with improved properties. Its pipeline products include S44HP, an…
NEXT offers secure and user-friendly fingerprint sensor technology for verification purposes in various…
We are a speciality pharmaceutical business committed to the creation and marketing of goods for people who…
Hemispherian Funding FAQs
What does Hemispherian do?
Hemispherian is a company in the field of biotechnology, specializing in developing innovative therapies for various forms of cancer.
How much funding has Hemispherian raised?
Hemispherian has raised $10.2M across 3 rounds on record. The most recent is an undisclosed round of $1.5M announced in Dec 2023.
When did Hemispherian last raise funding?
Hemispherian's most recent funding round on record is an undisclosed round of $1.5M, announced in Dec 2023.
Who is the CEO of Hemispherian?
Zeno Albisser is listed as CEO at Hemispherian.
Where is Hemispherian headquartered?
Hemispherian is based in Oslo, Norway.
How many employees does Hemispherian have?
Hemispherian is in the 1-10 employee band.
How does Hemispherian's funding compare to other Biotechnology startups?
Hemispherian's latest round of $1.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Hemispherian Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hemispherian is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.